Aegros in raising with $300m-plus float ahead
MELBOURNE: Blood plasma biotech Aegros has mapped out plans for $300 million-plus listing on the
MELBOURNE: Blood plasma biotech Aegros has mapped out plans for $300 million-plus listing on the
FEATURED
Special research team creates ‘predictive medicine’ AI tool
Gen Z fear they will be poorest generation
New development earmarked for hospitality and multigenerational living
Public notification opens for 25-unit project on former landfill
Nine-story homeless tower rejected by council in shock vote
Multigenerational affordable housing planned for regeneration site
INNOVATION
